A San Francisco court levels $289 Million in damages against the pesticide maker.

The Reproducibility Project: Cancer Biology initially aimed to replicate the results of 50 high-impact research articles.

The promise of immunotherapy is real. We now need to figure out how to maximize the number of patients the approach benefits.

The move follows two major corrections to a 2011 Nature paper, in which researchers demonstrated that a natural compound selectively kills cancer cells.

Accusations that Nazneen Rahman bullied employees at the Institute of Cancer Research in the U.K. stretch back 12 years.

The DNA-cutting enzyme used in the technique is not as precisely targeted as scientists had thought, and investors take notice.

Researchers plan to turn cancer cells into defectors, engineering them to kill the tumors from whence they came, and have tested the approach in mice.

Stem-cell–derived natural killer cells engineered in a similar way to CAR-T cells may pave the way to “off the shelf” cancer therapies that aren’t patient-specific.

Big data and empirical approaches to understanding diseases provide a limited picture of pathogenesis.